An insulin analogue with gamma-amino butyric acid substitution for A13Leu-A14Tyr.
An insulin A chain analogue, [A13-14 GABA, A21 Ala]A chain, for which the dipeptide Leu-Try at A13-A14 was substituted by a non-coded amino acid, gamma-amino butyric acid (GABA) and A21 Asn by Ala, was prepared by stepwise Fmoc solid-phase manual synthesis and then combined with the natural B chain of porcine insulin to yield an insulin analogue, [A13-14 GABA, A21Ala] porcine insulin (GABA substituted insulin). This insulin analogue still retains 50% in vivo biological activity and 59% in receptor binding capacity. It can also be crystallized. These results indicate that its overall conformation is similar to the native form and that the side chains of A13Leu and A14Tyr are not essential for insulin activity. In addition, the replacement of a normal C-N peptide bond by an unnatural C-C bond may have general meaning in structure and function studies of other proteins.
Huang
Y D
YD
State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry, Chinese Academy of Sciences. zhfe@sunm.shcnc.ac.cn
Yang
S Z
SZ
Feng
Y M
YM
Niu
C I
CI
D000595:Amino Acid Sequence; D000818:Animals; D003460:Crystallization; D007328:Insulin / Q000031:analogs & derivatives*; D007930:Leucine / Q000737:chemistry*; D013552:Swine; D014443:Tyrosine / Q000737:chemistry*; D005680:gamma-Aminobutyric Acid / Q000737:chemistry*
D007328:Insulin; D014443:Tyrosine; D005680:gamma-Aminobutyric Acid; D007930:Leucine